164 related articles for article (PubMed ID: 8381249)
1. Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization.
Green MS; Handsher R; Cohen D; Melnick JL; Slepon R; Mendelsohn E; Danon YL
Vaccine; 1993; 11(1):75-81. PubMed ID: 8381249
[TBL] [Abstract][Full Text] [Related]
2. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries.
Slater PE; Orenstein WA; Morag A; Avni A; Handsher R; Green MS; Costin C; Yarrow A; Rishpon S; Havkin O
Lancet; 1990 May; 335(8699):1192-5; discussion 1196-8. PubMed ID: 1971043
[TBL] [Abstract][Full Text] [Related]
3. Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany.
Eggers M; Terletskaia-Ladwig E; Rabenau HF; Doerr HW; Diedrich S; Enders G; Enders M
BMC Infect Dis; 2010 Dec; 10():347. PubMed ID: 21143885
[TBL] [Abstract][Full Text] [Related]
4. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
[TBL] [Abstract][Full Text] [Related]
5. Israel in the elimination phase of poliomyelitis--achievements and remaining problems.
Swartz TA; Handsher R
Public Health Rev; 1993-1994; 21(1-2):99-106. PubMed ID: 8041893
[TBL] [Abstract][Full Text] [Related]
6. Four-year follow-up of the immune status of young adults given a single booster dose of trivalent oral poliovaccine.
Green MS; Handsher R; Slepon R; Ashkenazi S; Mendelson E; Cohen D
Vaccine; 1994 May; 12(7):582-4. PubMed ID: 8085373
[TBL] [Abstract][Full Text] [Related]
7. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
[TBL] [Abstract][Full Text] [Related]
8. Poliomyelitis in Oman. I. The last outbreak?
Al-Dhahry SH; Koul RL; Al-Busaidy SM; Al-Awaidy ST; Al-Khusaiby SM; Suleman AJ
Acta Trop; 2001 Oct; 80(2):125-30. PubMed ID: 11600090
[TBL] [Abstract][Full Text] [Related]
9. Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children who missed routine programme.
Andrianarivelo MR; Boisier P; Rabarijaona L; Ratsitorahina M; Migliani R; Zeller H
Trop Med Int Health; 2001 Dec; 6(12):1032-9. PubMed ID: 11737841
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
[TBL] [Abstract][Full Text] [Related]
11. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
[TBL] [Abstract][Full Text] [Related]
12. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
Famulare M; Selinger C; McCarthy KA; Eckhoff PA; Chabot-Couture G
PLoS Biol; 2018 Apr; 16(4):e2002468. PubMed ID: 29702638
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of Oral Polio Vaccine and Salk Inactive Polio Vaccine Against Xinjiang Imported Type 1 Wild Poliovirus.
Yan D; Wang D; Zhu S; Zhang Y; Li X; Tang H; Guan J; Xu W
Clin Infect Dis; 2020 Apr; 70(9):1980-1984. PubMed ID: 31240315
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in China.
Li RC; Li CG; Wang HB; Luo HM; Li YP; Wang JF; Ying ZF; Yu WZ; Shu JD; Wen N; Vidor E
J Pediatric Infect Dis Soc; 2016 Sep; 5(3):287-96. PubMed ID: 26407255
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
[TBL] [Abstract][Full Text] [Related]
16. Serosurvey for polio antibodies.
Biberi-Moroeanu S; Munţiu A; Stoiculescu S
Virologie; 1988; 39(4):241-5. PubMed ID: 2851206
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.
Iwai M; Takizawa T; Nakayama T; Matsuura K; Yoshida H; Hasegawa S; Obara M; Horimoto E; Kurata T; Horie H
Scand J Infect Dis; 2008; 40(3):247-53. PubMed ID: 17907043
[TBL] [Abstract][Full Text] [Related]
18. Antibody titers against vaccine and contemporary wild poliovirus type 1 in children immunized with IPV+OPV and young adults immunized with OPV.
Lukashev AN; Yarmolskaya MS; Shumilina EY; Sychev DA; Kozlovskaya LI
Virus Res; 2016 Feb; 213():162-164. PubMed ID: 26657881
[TBL] [Abstract][Full Text] [Related]
19. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
[TBL] [Abstract][Full Text] [Related]
20. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
